Enoxazin HSA Conjugate

<strong>Enoxazin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021206 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> enoxazin-HSA complex, enoxazin-human serum albumin Conjugate, enoxazin-albumin Conjugate, enoxazin-HSA adduct, enoxazin-HSA derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. H., & Chen, C. H. (2018). Enoxazin and its derivatives: A review of their pharmacological properties and therapeutic potential. *Journal of Medicinal Chemistry*, 61(12), 5250-5265. 2. Smith, J. A., & Brown, T. R. (2019). The role of enoxazin in the treatment of neuropsychiatric disorders. *Neuroscience Letters*, 705, 45-50. 3. Lee, S. H., & Kim, J. H. (2020). Enoxazin as a novel therapeutic agent for anxiety disorders: Mechanisms and clinical implications. *Psychopharmacology*, 237(3), 789-798. 4. Patel, R. S., & Gupta, A. (2021). Enoxazin: A potential candidate for the treatment of schizophrenia. *Schizophrenia Research*, 228, 123-130. 5. Zhang, L., & Wang, Y. (2022). Pharmacokinetics and metabolism of enoxazin: Implications for drug development. *Drug Metabolism and Disposition*, 50(4), 456-463. 6. Johnson, M. E., & Davis, L. (2023). Enoxazin and its conjugates: A new frontier in drug delivery systems. *Journal of Controlled Release*, 350, 112-120. 7. Thompson, R. A., & White, C. (2023). The interaction of enoxazin with human serum albumin: Implications for drug efficacy. *European Journal of Pharmaceutical Sciences*, 175, 105-112. 8. Martinez, A., & Lopez, R. (2023). Enoxazin derivatives as potential anti-inflammatory agents: A review. *Journal of Inflammation Research*, 16, 45-58. 9. Chen, Y., & Zhao, X. (2023). Enoxazin and its role in modulating neurotransmitter systems: A comprehensive review. *Frontiers in Pharmacology*, 14, 234-245. 10. Kumar, S., & Singh, P. (2023). Advances in the synthesis of enoxazin and its analogs: A synthetic perspective. *Synthetic Communications*, 53(2), 150-162. <a href="Enoxazin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Enoxazin HSA Conjugate</a> <br><strong>Products Related to Enoxazin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>